Tumour-associated macrophages are related to progression in patients with metastatic melanoma following interleukin-2 based immunotherapy. 2006

Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
Institute of Medical Microbiology and Immunology, University of Aarhus, Denmark.

The aim of the present study was to analyze whether leukocyte subsets in peripheral blood and tumour biopsies obtained before treatment were able to predict response or survival in patients with metastatic melanoma following Interleukin-2 (IL-2) based immunotherapy. Flow cytometry was performed on peripheral blood for CD4(+) T cells, CD8(+) T cells and CD56(+) natural killer (NK) cells. Immunohistochemical analyses were used to identify CD4(+) T cells, CD8(+) T cells, CD57(+) NK cells and CD64(+) (macrophages) cells in tumour biopsies. High numbers of tumour-associated CD64(+) macrophages in tumour biopsies were statistically significantly associated with poor response to treatment. Our data suggest that tumour-associated macrophages may correlate negatively with response, which may be of biological importance for IL-2 based immunotherapy of malignant melanoma.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females

Related Publications

Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
October 2005, Melanoma research,
Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
January 1995, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
May 1992, The Mount Sinai journal of medicine, New York,
Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
August 2004, Cancer immunology, immunotherapy : CII,
Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
February 2009, Clinical cancer research : an official journal of the American Association for Cancer Research,
Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
November 2007, Danish medical bulletin,
Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
August 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
August 2006, Melanoma research,
Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
January 2006, Irish journal of medical science,
Bettina Dencker Hansen, and Henrik Schmidt, and Hans von der Maase, and Pia Sjoegren, and Ralf Agger, and Marianne Hokland
June 2004, Melanoma research,
Copied contents to your clipboard!